科技管理研究ScienceandTechnologyManagementResearch2023No.22023年第2期doi:10.3969/j.issn.1000-7695.2023.2.018我国生物医药科技成果转化的制约因素分析和战略规划建议孙立1，孟海华2（1.上海市投资促进服务中心/上海市中小企业上市促进中心，上海200125；2.上海市生物医药科技发展中心，上海201203）摘要：为提高我国生物医药科技成果转化率，缩短与美欧等国家和地区差距，推动生物医药产业快速向高能级发展，基于科技创新成果转化理论，从科技成果转化的流程、模式及其相关发展要素等方面对我国生物医药科技成果转化的制约因素进行全面分析，发现创新研发导向偏差、全国性知识网络转化不畅、专项资金支撑不足等是当前影响最为深刻的三大制约因素；据此提出应增强政府政策的针对性和实效性、提升国家创新体系的成果转化效能、全方位打造多层次科技成果转化金融体系等战略规划建议。关键词：生物医药科技成果转化；战略规划；中国中图分类号：C931.2；G301文献标志码：A文章编号：1000-7695（2023）2-0144-07AnalysisofRestrictiveFactorsandSuggestionsofStrategicPlanningfortheCommercializationofBiopharmaceuticalResearchandDevelopmentinChinaSunLi1,MengHaihua2(1.ShanghaiInvestmentPromotionServiceCenter/ShanghaiSEMsGoingPublicPromotionCenter,Shanghai200125,China;2.ShanghaiCenterofBiomedicineDevelopment,Shanghai201203,China)Abstract:InordertoimprovethecommercializationrateofChina'sbiopharmaceuticalresearchanddevelopment,shortenthegapwiththeUnitedStates,Europeandothercountriesandregions,andpromotetherapiddevelopmentofthebiopharmaceuticalindustrytothehigh-energylevel,basedontherelevanttheoriesofthetransformationofscientificandtechnologicalinnovationachievements,thispapercomprehensivelyanalyzestherestrictivefactorsofthecommercializationofbiopharmaceuticalresearchanddevelopmentinChinafromtheaspectsoftheprocess,model,andrelevantdevelopmentfactorsofthecommercializationofbiopharmaceuticalresearchanddevelopment,andfindsthatthedeviationoftheorientationofinnovationresearchanddevelopment,thepoorcommercializationofthenationalknowledgenetwork,andthelackofspecialfundsupportarethethreemostprofoundrestrictivefactorsatpresent.Basedonthis,itproposestostrength...
